The Pulmonary Hypertension Association’s (PHA’s) health and wellness series, PHA Connects: COVID-19 and Your Health, aims to educate and support our pulmonary hypertension (PH) community during the COVID-19 pandemic. PHA Connects provides patient education, live interviews and online events that matter to your health and wellness today. You can find additional COVID-19 resources at PHAssociation.org/COVID-19. PHA Connects is made possible through the support of our sponsors.
PHA Connects: Understanding the PH Drug Pipeline
Over the past few decades, there has been enormous growth in our understanding of pulmonary arterial hypertension (PAH), how it progresses and therapies available to patients. But much more research is needed to find ways to improve the quality of life for people living with PH. Join the Pulmonary Hypertension Association (PHA) Sept. 25 at 4 p.m. EDT for a virtual town hall on “Understanding the PH Drug Pipeline.” Pulmonologist Anna Hemnes will provide insight on the available PAH therapies, the biological pathways targeted and new treatments in the drug development pipeline.
About the Speaker
Anna Hemnes, M.D., is an associate professor of pulmonary and critical care medicine and assistant director of the Pulmonary Vascular Center at Vanderbilt University Medical Center in Nashville, Tennessee. She is chair-elect of PHA’s Scientific Leadership Council and an investigator for the PVDOMICS study, a clinical study supported by the National Heart, Lung and Blood Institute and PHA. Dr. Hemnes received her medical degree from Johns Hopkins University and completed her residency and fellowship at Johns Hopkins Hospital and Health System.